C31G is a potent broad spectrum antimicrobial agent, effective against gram positive and gram negative bacteria, yeast and fungi.C31G, vaginal gel is developed by Biosyn Inc. and has commenced enrollment...
- Mechanism
- Curator reviewed
The range of organisms killed by C31G has been extended to include enveloped viruses. Coupled with data indicating a low toxicity for mammalian cells, and a much wider range of anti-microbial activity than Nonoxynol-9, it appears that C31G is an ideal agent for use in decreasing the risk of transmission of organisms associated with STD. C31G is developed as a topical vaginal microbicide with broad-spectrum antibacterial and antiviral properties. C31G which has a high affinity for bacteria, fungi, yeast, and viruses while exhibiting low mammalian cell toxicity.
- Primary indication
- Investigated for use/treatment in contraception, HIV infection, and prevention of stdis.Curator reviewed
- Formula / weight
- C30H64N2O3 · 500.8408 g/mol (avg)
Resolves to
KMCBHFNNVRCAAH-UHFFFAOYSA-NSMILESCCCCCCCCCCCC[N+](C)(C)[O-].CCCCCCCCCCCC[N+](C)(C)CC([O-])=OWhat you can answer from here — as of April 02, 2025
Which drugs share a target with C31G, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account